Add like
Add dislike
Add to saved papers

In vitro scolicidal effect of Calendula officinalis, Artemisia dracunculus, Artemisia absinthium, and Ferula assafoetida extracts against hydatid cyst protoscolices.

Echinococcus granulosus is the etiologic agent of cystic echinococcosis. Numerous research studies have been conducted on natural scolicidal agents to inactivate protoscolices during surgery. This study was undertaken to compare the in vitro scolicidal effects of hydroalcoholic extracts of Calendula officinalis, Artemisia dracunculus, Artemisia absinthium and Ferula assafoetida. The scolicidal activities of the extracts were tested at different concentrations following incubation periods of 10, 30 and 60 min. The chemical composition of the hydroalcoholic extracts were analyzed using Gas Chromatography-Mass Spectrometry (GC-MS). The major chemical components of C. officinalis, A. dracunculus, A. absinthium and F. assafoetida were identified as n-Docosane (14.17%), 2H-1-benzopyran-2-one, 7-methoxy (54.96%), n-Docosane (9.72%) and 2-methoxy-3-methyl-butyric acid, methyl ester (13.9%), respectively. The results showed that the hydroalcoholic extracts of A. absinthium and F. assafoetida at a concentration of 250 mg/ml resulted in killing 100% of the protoscolices at 60 minutes, while the concentration of 250 mg/ml of hydroalcoholic extract of C. officinalis and A. dracunculus resulted in killing 42.33% and 65.67%, respectively. The findings of the present study showed that A. absinthium and F. assafoetida have potent scolicidal effects. However, additional in vivo studies are required to confirm the efficacy of these plant-derived extracts against hydatid cyst for their clinical use.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app